Regulus

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
Applicant: REGULUS THERAPEUTICS INCPriority: 2004
US
41 publications
Methods for treatment of alport syndrome
Applicant: REGULUS THERAPEUTICS INCPriority: 2013
US
5 publications
MicroRNA compounds and methods for modulating MIR-21 activity
Applicant: BHAT BALKRISHENPriority: 2012
US
6 publications
MicroRNA compounds and methods for modulating miR-122
Applicant: REGULUS THERAPEUTICS INCPriority: 2014
CN
US
7 publications
MODIFIED OLIGONUCLEOTIDE FOR TREATING POLYCYSTIC KIDNEY DISEASE
Applicant: REGULUS THERAPEUTICS INCPriority: 2023
CN
EP
WO
3 publications
METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
Applicant: REGULUS THERAPEUTICS INCPriority: 2021
CN
EP
US
WO
7 publications
COMPOUND FOR USE IN METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
Applicant: REGULUS THERAPEUTICS INCPriority: 2024
WO
MicroRNA compounds and methods for modulating miR-21 activity
Applicant: REGULUS THERAPEUTICS INCPriority: 2013
US
6 publications